Cerence Q1 revenue slightly beats estimates

Reuters
Feb 05
Cerence Q1 revenue slightly beats estimates

Overview

  • Conversational AI firm's fiscal Q1 revenue slightly beat analyst expectations

  • Company achieved record free cash flow of $35.6 mln in fiscal Q1

Outlook

  • Cerence expects Q2 revenue between $58 mln and $62 mln

  • Company projects Q2 gross margins between 71% and 72%

  • Cerence reaffirms FY2026 revenue guidance of $300 mln to $320 mln

Result Drivers

  • PATENT LICENSE REVENUE - Q1 revenue included a $49.5 mln payment from a patent license agreement with Samsung

  • CUSTOMER MOMENTUM - Cerence xUI gained traction with five automaker programs and positive reception at CES 2026

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Slight Beat*

$115.10 mln

$114.48 mln (4 Analysts)

Q1 EPS

-$0.12

Q1 Net Income

-$5.20 mln

Q1 Gross Margin

86.3%

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy."

  • Wall Street's median 12-month price target for Cerence Inc is $11.00, about 6.2% above its February 3 closing price of $10.36

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nGNX51Wxq

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10